What dose of Human Actrapid (insulin) should be administered to an adult patient with diabetes and severe hyperglycemia (capillary blood glucose level of 480)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Insulin Dosing for Severe Hyperglycemia (CBG 480 mg/dL)

For a capillary blood glucose of 480 mg/dL (26.6 mmol/L), administer an immediate intravenous bolus of 0.15 units/kg of regular insulin (Human Actrapid), followed by a continuous intravenous infusion at 0.1 units/kg/hour until blood glucose falls to 250-300 mg/dL. 1, 2

Critical Initial Assessment

Before administering insulin, you must:

  • Exclude hypokalemia (K+ <3.3 mEq/L) - if present, correct potassium first before giving insulin to avoid life-threatening cardiac arrhythmias 1, 2
  • Check for ketosis - in patients with type 1 diabetes or insulin-treated type 2 diabetes with glucose >300 mg/dL (16.5 mmol/L), measure urine or blood ketones to rule out diabetic ketoacidosis 3
  • Assess for hyperosmolarity - measure serum sodium and calculate effective osmolality (2[Na] + glucose/18) to exclude hyperosmolar hyperglycemic state if osmolality >320 mOsm/kg 3, 1

Insulin Dosing Protocol

For Diabetic Ketoacidosis or Severe Hyperglycemia:

  • Initial IV bolus: 0.15 units/kg of regular insulin (Human Actrapid) 1, 2
  • Continuous infusion: 0.1 units/kg/hour (typically 5-7 units/hour in adults) 1, 2
  • Target glucose reduction: 50-75 mg/dL per hour 1, 2
  • If glucose fails to drop by 50 mg/dL in the first hour: double the insulin infusion rate every hour until steady decline achieved 1

Transition to Subcutaneous Insulin:

  • When glucose reaches 250 mg/dL: decrease IV insulin to 0.05-0.1 units/kg/hour and add 5-10% dextrose to IV fluids 1, 2
  • Before stopping IV insulin: give subcutaneous basal insulin, with total subcutaneous dose = half of the 24-hour IV insulin amount 3
  • Split subcutaneous dose: 50% as basal insulin (given once in evening), 50% divided among three meals as rapid-acting insulin 3

Alternative Approach for Mild Cases Without Ketoacidosis:

If the patient has mild hyperglycemia without ketosis, adequate hydration, and can take subcutaneous insulin:

  • Initial subcutaneous dose: 0.4-0.6 units/kg as total daily dose, with half given as intravenous bolus and half as subcutaneous/intramuscular injection 1
  • Maintenance: 0.1 units/kg/hour subcutaneously or intramuscularly 1

Critical Monitoring Requirements

  • Check glucose every 1-2 hours during IV insulin infusion 1, 2
  • Monitor serum potassium every 2-4 hours - add 20-40 mEq/L potassium to IV fluids once urine output established and K+ >3.3 mEq/L 1, 2
  • Check venous pH and anion gap every 2-4 hours if ketoacidosis present 1

Essential Pitfalls to Avoid

  • Never give insulin if potassium <3.3 mEq/L - correct hypokalemia first to prevent cardiac arrest 1, 2
  • Never use sliding scale insulin alone for glucose of 480 mg/dL - this reactive approach leads to dangerous glucose fluctuations and is explicitly condemned by all major guidelines 4, 5
  • Never give rapid-acting insulin at bedtime for correction - this significantly increases nocturnal hypoglycemia risk 5
  • Do not stop IV insulin abruptly - overlap with subcutaneous basal insulin by 1-2 hours to prevent rebound hyperglycemia 3

Fluid Resuscitation (Concurrent with Insulin)

  • Initial fluid: 0.9% normal saline at 15-20 mL/kg/hour (1-1.5 L) in the first hour 1, 2
  • Subsequent fluid: 250-500 mL/hour based on hydration status and corrected sodium 1, 2
  • Average requirement: 9 liters over 48 hours for hyperosmolar states 6

References

Related Questions

At what glucose level should I hold Humalog (insulin lispro)?
Why are non-diabetic patients placed on sliding scale insulin (SSI) while fasting?
What does a basal insulin level of 2.3 (microunits per milliliter) indicate in a 48-year-old man with no known diabetes?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
What is the skin penetration of doxycycline in patients with Impaired renal function?
How do you diagnose opioid use disorder in a patient with moderately severe withdrawal symptoms?
What are the post-operative management recommendations for an adult patient with a history of pancreatic disease, status post total pancreatectomy with double bypass, currently admitted to the hospital?
What is the cause of painless swelling in the hands and forearm of a 46-year-old woman?
Is Dulcolax (bisacodyl) suppository safe and what is the recommended dose for elderly patients with constipation?
What is the significance of C3 (Complement 3) and C4 (Complement 4) levels in patients with Hemolytic Uremic Syndrome (HUS), particularly those with atypical HUS (aHUS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.